PT  - JOURNAL ARTICLE
AU  - Beena E. Thomas
AU  - J. Vignesh Kumar
AU  - M. Chiranjeevi
AU  - Daksha Shah
AU  - Amit Khandewale
AU  - Jessica E. Haberer
AU  - Kenneth H. Mayer
AU  - Ramnath Subbaraman
TI  - Evaluation of the accuracy of 99DOTS, a novel cellphone-based strategy for monitoring adherence to tuberculosis medications
AID  - 10.1101/19011197
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 19011197
4099  - http://medrxiv.org/content/early/2019/11/05/19011197.short
4100  - http://medrxiv.org/content/early/2019/11/05/19011197.full
AB  - 99DOTS is a cellphone-based strategy for monitoring tuberculosis medication adherence. In a cohort of 650 Indian tuberculosis patients, we compared 99DOTS’ adherence record against results of urine isoniazid tests collected during unannounced home visits. 99DOTS had suboptimal accuracy for measuring adherence, partly due to poor patient engagement with 99DOTS.Competing Interest StatementBET, JVK, CM, AK, and RS are conducting research evaluating the implementation of 99DOTS and evriMED (a digital pillbox) in India, supported by the Bill and Melinda Gates Foundation; none of them have any financial interest in these technologies. JEH is currently conducting research on the Wisepill device and evriMED1000 (digital pillboxes); she has no financial interest in these technologies. KHM is providing mentorship for research for research evaluating the use of ingestible sensors; he does not have any financial interest in this technology. DS: No conflicts.Funding StatementThis research was primarily supported by grants from the Bill and Melinda Gates Foundation (OPP1154670 and OPP1154665). RS also received support from a Harvard Catalyst KL2/Catalyst Medical Investigator Training Award (KL2 TR001100), a grant from the Harvard Center for AIDS Research (5P30AI060354-13), and a Doris Duke Clinical Scientist Development Award (grant #2018095). The funding bodies had no role in study design, data collection, data analysis, data interpretation, or manuscript writing.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRequests for access to the de-identified dataset can be made by contacting Dr. Beena Thomas (beenathomas{at}nirt.res.in), although access to these data may be limited by NIRT/Indian Council of Medical Research policies.